Int J Clin Pract. 2005 Sep;59(9):1070-81.

Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.

Source

University Department of Medicine, City Hospital, Birmingham, UK.

Abstract

Atherosclerosis is a dynamic process and timely introduction of pharmacological treatment can have a significant bearing on the patient's health and outcome. In addition to treating the culprit lesion mechanically, admission for percutaneous coronary interventions (PCI) for coronary artery disease (CAD) gives an opportunity for the interventional cardiologist to optimize medical therapy. The aim of this review is to provide an overview of the current medical literature pertaining to cardiovascular (CV) risk reduction and vascular event prevention in the setting of PCI, with emphasis on antiplatelet therapies, beta-blockers, HMG-Co A reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors, with regard to therapy optimization during PCI and for chronic CAD. We discuss the effects of these oral therapies in reducing ischaemic events, thus augmenting the benefits of PCI, as well as preventing recurrent CV events after the procedure.

PMID:: 16115184; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Angioplasty - MedlinePlus Health Information

Molecular Biology Databases

ACETYLSALICYLIC ACID - HSDB

Supplemental Content

Related citations

Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention? [Postgrad Med J. 2005]
Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
Fox DJ, Kibiro M, Eichhöfer J, Curzen NP. Postgrad Med J. 2005 Jun; 81(956):401-3.
Review Optimal medical management of peripheral arterial disease. [Vasc Endovascular Surg. 2006]
Review Optimal medical management of peripheral arterial disease.
Rice TW, Lumsden AB. Vasc Endovascular Surg. 2006 Aug-Sep; 40(4):312-27.
Review Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation. [Circulation. 2003]
Review Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
Kereiakes DJ. Circulation. 2003 Oct 21; 108(16 Suppl 1):III22-7.
Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry. [Can J Cardiol. 2003]
Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
Eisenberg MJ, Okrainec K, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R, Tsang J, Huynh T, Sedlis S, et al. Can J Cardiol. 2003 Aug; 19(9):1009-15.
Review Secondary prevention of ischaemic cardiac events. [Clin Evid. 2006]
Review Secondary prevention of ischaemic cardiac events.
Gami A. Clin Evid. 2006 Jun; (15):195-228.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Percutaneous coronary interventions for coronary artery disease: the long and sh...
Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
Int J Clin Pract. 2005 Sep ;59(9):1070-81.

PubMed
Critical review of unstable angina and non-ST elevation myocardial infarction.
Critical review of unstable angina and non-ST elevation myocardial infarction.
Postgrad Med J. 2002 Dec ;78(926):717-26.

PubMed
Coronary calcification, coronary disease risk factors, C-reactive protein, and a...
Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.
J Am Coll Cardiol. 2005 Jul 5 ;46(1):158-65.

PubMed
Cardiac markers for myocardial infarction. A brief review.
Cardiac markers for myocardial infarction. A brief review.
Am J Clin Pathol. 2002 Dec ;118 Suppl:S93-9.

PubMed
Mouse genetic models for prepulse inhibition: an early review.
Mouse genetic models for prepulse inhibition: an early review.
Mol Psychiatry. 2002 ;7(10):1039-53.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information